Find Fosfomycin Trometamol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

4RELATED EXCIPIENT COMPANIES

8EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 78964-85-9 (tromethamine), [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium;hydroxy-[(2r,3s)-3-methyloxiran-2-yl]phosphinate, Tromethamine-fosfomycin, Fosfotricin, Monurol sachet, Fosfomycin compd. with trometamol
Molecular Formula
C7H18NO7P
Molecular Weight
259.19  g/mol
InChI Key
QZJIMDIBFFHQDW-LMLSDSMGSA-N

Fosfomycin Trometamol
An antibiotic produced by Streptomyces fradiae.
1 2D Structure

Fosfomycin Trometamol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium;hydroxy-[(2R,3S)-3-methyloxiran-2-yl]phosphinate
2.1.2 InChI
InChI=1S/C4H11NO3.C3H7O4P/c5-4(1-6,2-7)3-8;1-2-3(7-2)8(4,5)6/h6-8H,1-3,5H2;2-3H,1H3,(H2,4,5,6)/t;2-,3+/m.0/s1
2.1.3 InChI Key
QZJIMDIBFFHQDW-LMLSDSMGSA-N
2.1.4 Canonical SMILES
CC1C(O1)P(=O)(O)[O-].C(C(CO)(CO)[NH3+])O
2.1.5 Isomeric SMILES
C[C@H]1[C@H](O1)P(=O)(O)[O-].C(C(CO)(CO)[NH3+])O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Fosfomycin

2. Fosfomycin Trometamol Salt

3. Fosfomycin Tromethamine

4. Phosphomycin

5. Phosphonomycin

6. Tromethamine, Fosfomycin

2.2.2 Depositor-Supplied Synonyms

1. 78964-85-9 (tromethamine)

2. [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium;hydroxy-[(2r,3s)-3-methyloxiran-2-yl]phosphinate

3. Tromethamine-fosfomycin

4. Fosfotricin

5. Monurol Sachet

6. Fosfomycin Compd. With Trometamol

7. Einecs 279-018-8

8. Fosfomycin Tromethaminel

9. Unii-7fxw6u30gy

10. Akos015896108

11. Ac-4209

12. Ks-1266

13. (2r-cis)-(3-methyloxiranyl)phosphonic Acid, Compound With 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1)

2.3 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 259.19 g/mol
Molecular Formula C7H18NO7P
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass259.08208891 g/mol
Monoisotopic Mass259.08208891 g/mol
Topological Polar Surface Area161 Ų
Heavy Atom Count16
Formal Charge0
Complexity190
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content

Fosfomycin Trometamol

About the Company : Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufac...

Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufacturing professionals, the company focuses on innovating and manufacturing semi-synthetic, synthetic, and fermentation-based APIs. Its R&D facility is equipped with advanced technology for synthesis, extraction, isolation, purification, and upstream fermentation, with active work in process chemistry for therapeutic molecules. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Sumar Biotech

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Fosfomycin Trometamol

About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of experience in formulation development, manufacturing, and commercialization. Its portfoli...

Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of experience in formulation development, manufacturing, and commercialization. Its portfolio includes DC granules, herbal and food supplements, APIs, and finished formulations such as tablets, capsules, syrups, and ointments. With WHO-GMP certification and a DSIR-certified R&D center, the company ensures quality and innovation, exporting to LATAM, the Middle East, Africa, Asia, and CIS regions, and offering formulation and marketing support. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Octavius Pharma

03

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Fosfomycin

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Fosfomycin

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

05

Bioquim

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.

Flag Spain
Digital Content Digital Content

Fosfomycin Trometamol

About the Company : Bioquim is a European company specializing in bulk oral and sterile APIs for the pharmaceutical industry. With over 40 years of experience, the company supplies corticosteroids, pe...

Bioquim is a European company specializing in bulk oral and sterile APIs for the pharmaceutical industry. With over 40 years of experience, the company supplies corticosteroids, peptides, amino acids, penicillin derivatives, non-penicillin antibiotics, and HPAPIs for human and veterinary use. Bioquim operates GMP-compliant, state-of-the-art facilities and also offers Custom Synthesis and Contract Manufacturing services, supported by expertise in chemical synthesis and sterile API lyophilization. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Bioquim

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Fosfomycin Trometamol

About the Company : Honour is a leading global CDMO and trusted manufacturer of specialty chemicals and ingredients, with seven world-class facilities meeting global safety and quality standards. Thro...

Honour is a leading global CDMO and trusted manufacturer of specialty chemicals and ingredients, with seven world-class facilities meeting global safety and quality standards. Through Honour Synthesis and Honour Specialty, it delivers innovative solutions leveraging chemistry expertise. Its team of over 2,500 professionals partners with pharmaceutical, biotech, and specialty industries worldwide to develop practical, scalable solutions. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTogether we can improve the quality of life

Flag India
Digital Content Digital Content

Fosfomycin Trometamol

About the Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities...

Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities and partners with 16+ plants. Holding USFDA, EU-GMP, WHO-GMP, and other certifications, it is the largest exporter for 12 molecules worldwide. With robust regulatory compliance (DMF, CEP, ICH Q7), Shamrock is the preferred API partner in India. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

About the Company : Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healt...

Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare Ltd. have metamorphosed into specialty company and focused on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries. Bajaj healthcare Ltd. in its shot life span has gained loyalty from national and international customers and our products enjoy good fame in the overseas market.
blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

About the Company : Northeast Pharmaceutical Group Co., Ltd ( NEPG ) is a large-scale comprehensive pharmaceutical enterprise in China.It is composed of three major business segments, i.e. 1. chemical...

Northeast Pharmaceutical Group Co., Ltd ( NEPG ) is a large-scale comprehensive pharmaceutical enterprise in China.It is composed of three major business segments, i.e. 1. chemical synthetic API and bio-fermentation API, 2. western medicinal preparation and micro-ecological preparation, 3. medical business distribution. NEPG produces 12 major series, mainly covering Vitamin Series, Antibiotics, Anti-AIDS, Digestives, Narcotic medicines, Cardiovascular and Cerebrovascular medicines, etc. NEPG is proud of being the first Vitamin C producer in China,
blank

10

Scimplify

India
PEGS Boston Summit
Not Confirmed
arrow

Scimplify

India
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

About the Company : Scimplify is a science-first company specializing in end-to-end development and manufacturing of specialty chemicals. We support the entire product life cycle, from contract resear...

Scimplify is a science-first company specializing in end-to-end development and manufacturing of specialty chemicals. We support the entire product life cycle, from contract research to commercial chemical production across pharmaceuticals, agrochemicals, industrial chemicals, flavors, fragrances, food, and personal care. Our proprietary platform, ATOMS, streamlines procurement, offers real-time visibility, and ensures regulatory compliance. With 25+ reaction capabilities, we help businesses scale from lab to commercial production efficiently and reliably.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Fosfomycin, an antibiotic, targets UDP-N-acetylglucosamine 1-carboxyvinyltransferase, showing promise in treating complicated urinary tract infections (cUTI).


Lead Product(s): Fosfomycin Trometamol,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Contepo

Study Phase: Approved FDFProduct Type: Antibiotic

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 04, 2025

blank

01

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : Fosfomycin, an antibiotic, targets UDP-N-acetylglucosamine 1-carboxyvinyltransferase, showing promise in treating complicated urinary tract infections (cUTI).

Product Name : Contepo

Product Type : Antibiotic

Upfront Cash : Inapplicable

November 04, 2025

blank
  • Development Update

Details:

Uroxin is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Tract Infections.


Lead Product(s): Uroxin,Fosfomycin Trometamol

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Undisclosed

Sponsor: pharmaSuisse

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 26, 2024

blank

02

University of Campania Luigi Vanvitelli

Country
arrow
PEGS Boston Summit
Not Confirmed

University of Campania Luigi Vanvitelli

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Uroxin is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Tract Infections.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

October 26, 2024

blank
  • Development Update

Details:

Fosfomycin is a Antibiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Cystitis.


Lead Product(s): Fosfomycin Trometamol,Inapplicable

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Antibiotic

Sponsor: Petrovax

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 14, 2023

blank

03

PharmaLinea

Country
arrow
PEGS Boston Summit
Not Confirmed

PharmaLinea

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Fosfomycin is a Antibiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Cystitis.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

July 14, 2023

blank
  • Development Update

Details:

Fosfomycin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Tract Infections.


Lead Product(s): Fosfomycin Trometamol,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Antibiotic

Sponsor: ZonMw | Saltro

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 24, 2022

blank

04

ZonMw

Country
arrow
PEGS Boston Summit
Not Confirmed

ZonMw

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Fosfomycin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Tract Infections.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

February 24, 2022

blank
  • Development Update

Details:

Fosfomycin trometamol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Tract Infections.


Lead Product(s): Fosfomycin Trometamol,Nitrofurantoin,Pivmecillinam Hydrochloride

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Balearic Islands Health Service | Instituto de Investigación Sanitaria Aragón | Gerencia de Atención Primaria, Madrid

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 13, 2021

blank

05

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Country
arrow
PEGS Boston Summit
Not Confirmed

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Fosfomycin Trometamol,Nitrofurantoin,Pivmecillinam Hydrochloride

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : Balearic Islands Health Service | Instituto de Investigación Sanitaria Aragón | Gerencia de Atención Primaria, Madrid

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Fosfomycin trometamol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Tract Infections.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 13, 2021

blank
  • Development Update

Details:

Fosfomycin Tromethamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Urinary Tract Infections.


Lead Product(s): Fosfomycin Trometamol,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Laboratorios Senosiain

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 24, 2019

blank

06

INC Salvador Zubirán

Country
arrow
PEGS Boston Summit
Not Confirmed

INC Salvador Zubirán

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Fosfomycin Tromethamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Urinary Tract Infections.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 24, 2019

blank
  • Development Update

Details:

Ciprofloxacin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infections.


Lead Product(s): Ciprofloxacin,Trimethoprim,Sulfamethoxazole,Fosfomycin Trometamol,Pivmecillinam Hydrochloride,Amoxicillin Trihydrate,Clavulanate Acid

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Antibiotic

Sponsor: ZonMw

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 24, 2017

blank

07

Radboud University Medical Center

Country
arrow
PEGS Boston Summit
Not Confirmed

Radboud University Medical Center

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Ciprofloxacin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infections.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

July 24, 2017

blank
  • Development Update

Details:

Amikacin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Amikacin,Fosfomycin Trometamol

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Antibiotic

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 16, 2016

blank

08

Cardeas Pharma

Country
arrow
PEGS Boston Summit
Not Confirmed

Cardeas Pharma

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Amikacin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

March 16, 2016

blank

Details:

Centaurium Erythraea is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Tract Infections.


Lead Product(s): Centaurium Erythraea,Levisticum Officinale,Rosmarinus Officinalis,Fosfomycin Trometamol

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Plant Extract/Herbal

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 24, 2015

blank

09

Bionorica SE

Germany
arrow
PEGS Boston Summit
Not Confirmed

Bionorica SE

Germany
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Centaurium Erythraea,Levisticum Officinale,Rosmarinus Officinalis,Fosfomycin Trometamol

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Centaurium Erythraea is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Tract Infections.

Product Name : Undisclosed

Product Type : Plant Extract/Herbal

Upfront Cash : Inapplicable

December 24, 2015

blank
  • Development Update

Details:

Amikacin is a Antibiotic drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pneumonia, Bacterial.


Lead Product(s): Amikacin,Fosfomycin Trometamol

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Antibiotic

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 18, 2014

blank

10

Cardeas Pharma

Country
arrow
PEGS Boston Summit
Not Confirmed

Cardeas Pharma

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Amikacin is a Antibiotic drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pneumonia, Bacterial.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

August 18, 2014

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Zentiva NV

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Fosfomycin Trometamol

Brand Name : Ffomicina

Dosage Form : Fosfomycin 3.000Mg 2 Units

Dosage Strength : for OS 2 bust 3 g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Phosfomycin

Brand Name : PHOSFOMICIN THINK

Dosage Form : Granules For Oral Solution

Dosage Strength : 3 g

Packaging : 2 UNITS 3000 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Towa Pharmaceutical

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Fosfomycin Trometamol

Brand Name : Fosfomicina Pensa

Dosage Form : Granule For Oral Solution

Dosage Strength : 3G

Packaging :

Approval Date : 15-04-2012

Application Number : 75775

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

Brand Name : Fosfomicina Kern Pharma

Dosage Form : Granule For Oral Solution

Dosage Strength : 3G

Packaging :

Approval Date : 20-03-2012

Application Number : 75651

Regulatory Info : Authorized

Registration Country : Spain

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

Brand Name : Fosfomicina Labiana

Dosage Form : Granule For Oral Solution In Sachet

Dosage Strength : 2G

Packaging :

Approval Date : 13-07-2016

Application Number : 81061

Regulatory Info : Cancelled

Registration Country : Spain

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

Brand Name : Fosfomycin Qualigen

Dosage Form : Granule For Oral Solution

Dosage Strength : 3G

Packaging :

Approval Date : 13-10-2010

Application Number : 72847

Regulatory Info : Authorized

Registration Country : Spain

blank

07

SF GROUP SRL

Italy
PEGS Boston Summit
Not Confirmed
arrow

SF GROUP SRL

Italy
arrow
PEGS Boston Summit
Not Confirmed

Phosfomycin

Brand Name : LOWER

Dosage Form : Granules For Oral Solution

Dosage Strength : 3 g

Packaging : 2 UNITS 3000 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

Brand Name : #VALUE!

Dosage Form : Fosfomycin 3.000Mg 2 Units' Oral Use

Dosage Strength : AD os groun 2 bust 3 g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

MYLAN SpA

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

MYLAN SpA

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

Brand Name : Ffomicina

Dosage Form : Fosfomycin 3.000Mg 2 Units' Oral Use

Dosage Strength : AD os grat 2 bust 3 g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

S.F.GROUP Srl

Country
PEGS Boston Summit
Not Confirmed
arrow

S.F.GROUP Srl

Country
arrow
PEGS Boston Summit
Not Confirmed

Fosfomycin Trometamol

Brand Name : Urof

Dosage Form : Fosfomycin 3.000Mg 2 Units' Oral Use

Dosage Strength : for OS 2 bust 3 g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Thickeners and Stabilizers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 78964-85-9 / Fosfomycin Trometamol API manufacturers, exporters & distributors?

Fosfomycin Trometamol manufacturers, exporters & distributors 1

93

PharmaCompass offers a list of Fosfomycin Trometamol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Fosfomycin Trometamol manufacturer or Fosfomycin Trometamol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosfomycin Trometamol manufacturer or Fosfomycin Trometamol supplier.

API | Excipient name

Fosfomycin Trometamol

Synonyms

78964-85-9 (tromethamine), [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium;hydroxy-[(2r,3s)-3-methyloxiran-2-yl]phosphinate, Tromethamine-fosfomycin, Fosfotricin, Monurol sachet, Fosfomycin compd. with trometamol

Cas Number

78964-85-9

About Fosfomycin Trometamol

An antibiotic produced by Streptomyces fradiae.

MONUROL Manufacturers

A MONUROL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MONUROL, including repackagers and relabelers. The FDA regulates MONUROL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MONUROL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MONUROL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

MONUROL Suppliers

A MONUROL supplier is an individual or a company that provides MONUROL active pharmaceutical ingredient (API) or MONUROL finished formulations upon request. The MONUROL suppliers may include MONUROL API manufacturers, exporters, distributors and traders.

click here to find a list of MONUROL suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

MONUROL USDMF

A MONUROL DMF (Drug Master File) is a document detailing the whole manufacturing process of MONUROL active pharmaceutical ingredient (API) in detail. Different forms of MONUROL DMFs exist exist since differing nations have different regulations, such as MONUROL USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A MONUROL DMF submitted to regulatory agencies in the US is known as a USDMF. MONUROL USDMF includes data on MONUROL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MONUROL USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of MONUROL suppliers with USDMF on PharmaCompass.

MONUROL JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The MONUROL Drug Master File in Japan (MONUROL JDMF) empowers MONUROL API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the MONUROL JDMF during the approval evaluation for pharmaceutical products. At the time of MONUROL JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of MONUROL suppliers with JDMF on PharmaCompass.

MONUROL KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a MONUROL Drug Master File in Korea (MONUROL KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of MONUROL. The MFDS reviews the MONUROL KDMF as part of the drug registration process and uses the information provided in the MONUROL KDMF to evaluate the safety and efficacy of the drug.

After submitting a MONUROL KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their MONUROL API can apply through the Korea Drug Master File (KDMF).

click here to find a list of MONUROL suppliers with KDMF on PharmaCompass.

MONUROL CEP

A MONUROL CEP of the European Pharmacopoeia monograph is often referred to as a MONUROL Certificate of Suitability (COS). The purpose of a MONUROL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MONUROL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MONUROL to their clients by showing that a MONUROL CEP has been issued for it. The manufacturer submits a MONUROL CEP (COS) as part of the market authorization procedure, and it takes on the role of a MONUROL CEP holder for the record. Additionally, the data presented in the MONUROL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MONUROL DMF.

A MONUROL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MONUROL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of MONUROL suppliers with CEP (COS) on PharmaCompass.

MONUROL NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MONUROL as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for MONUROL API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture MONUROL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain MONUROL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MONUROL NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of MONUROL suppliers with NDC on PharmaCompass.

MONUROL GMP

MONUROL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of MONUROL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right MONUROL GMP manufacturer or MONUROL GMP API supplier for your needs.

MONUROL CoA

A MONUROL CoA (Certificate of Analysis) is a formal document that attests to MONUROL's compliance with MONUROL specifications and serves as a tool for batch-level quality control.

MONUROL CoA mostly includes findings from lab analyses of a specific batch. For each MONUROL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

MONUROL may be tested according to a variety of international standards, such as European Pharmacopoeia (MONUROL EP), MONUROL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MONUROL USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty